首页> 外国专利> ADENOVIRAL TARGETING AND MANIPULATION OF IMMUNE SYSTEM RESPONSE USING TARGETING PEPTIDES

ADENOVIRAL TARGETING AND MANIPULATION OF IMMUNE SYSTEM RESPONSE USING TARGETING PEPTIDES

机译:利用靶向肽对免疫系统的反应进行抗原靶向和操纵

摘要

The present invention concerns methods and compositions for in vivo and in vitro targeting. A large number of targeting peptides directed towards human organs, tissues or cell types are disclosed. The peptides are of use for targeted delivery of therapeutic agents, including but not limited to gene therapy vectors. A novel class of gene therapy vectors is disclosed. Certain of the disclosed peptides have therapeutic use for inhibiting angiogenesis, inhibiting tumor growth, inducing apoptosis, inhibiting pregnancy or inducing weight loss. Methods of identifying novel targeting peptides in humans, as well as identifying endogenous receptor-ligand pairs are disclosed. Methods of identifying novel infectious agents that are causal for human disease states are also disclosed. A novel mechanism for inducing apoptosis is further disclosed.
机译:本发明涉及用于体内和体外靶向的方法和组合物。公开了许多针对人体器官,组织或细胞类型的靶向肽。所述肽可用于靶向递送治疗剂,包括但不限于基因治疗载体。公开了新型的基因治疗载体。某些公开的肽具有治疗用途,用于抑制血管生成,抑制肿瘤生长,诱导凋亡,抑制妊娠或引起体重减轻。公开了鉴定人中新型靶向肽以及鉴定内源性受体-配体对的方法。还公开了鉴定对人类疾病状态起因的新型传染原的方法。进一步公开了诱导凋亡的新机制。

著录项

  • 公开/公告号EP1315512A2

    专利类型

  • 公开/公告日2003-06-04

    原文格式PDF

  • 申请/专利权人 BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM;

    申请/专利号EP20010970682

  • 发明设计人 ARAP WADIH;PASQUALINI RENATA;

    申请日2001-09-07

  • 分类号A61K38/00;A61K39/00;A61K39/21;C12P21/08;C07K16/28;C07K16/46;C07K16/42;

  • 国家 EP

  • 入库时间 2022-08-21 23:49:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号